Who Paid My Doc
A Phase 2/Phase 3, Multicenter, Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled Adaptive Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
ClinicalTrials.gov NCT06699849
Research payments
$400,882
Through program year 2025, $400,882 in research payments was reported against A Phase 2/Phase 3, Multicenter, Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled Adaptive Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis, across 167 payments, paid by CSL Behring.
- Paid by
- CSL Behring
- ClinicalTrials.gov
- NCT06699849
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $400,882 | 167 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Laura De Castro Pittsburgh, PA Named on 26 payments
- Jennifer Vaughn Columbus, OH Named on 22 payments
- John Strouse Baltimore, MD Named on 21 payments
- Robin Miller Wilmington, DE Named on 19 payments
- Caroline Freiermuth Durham, NC Named on 16 payments
- Ellen Friedman Bronx, NY Named on 14 payments
- Richard Wilkerson Baltimore, MD Named on 6 payments
- Ramasubramanian Kalpatthi Kansas City, MO Named on 6 payments
- Thomas Harrington Miami, FL Named on 6 payments
- Carolyn Saccente Little Rock, AR Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.